Sinopharm Technology Co., Ltd. (08156) announced annual results. Loss attributable to shareholders of HK$9.142 million increased sharply by 954.44% year-on-year

According to the Zhitong Finance App, Sinopharm Technology Co., Ltd. (08156) announced results for the year ended June 30, 2026, with revenue of HK$45.82 million, a year-on-year decrease of 25.58%. The loss attributable to the owner of the company was HK$9.142 million, a significant increase of 954.44% over the previous year. Loss per share was HK1.97 cents.

According to the announcement, the Board of Directors believes that the main reason for the increase in losses attributable to equity holders is the net impact of: (i) a significant year-on-year decline in revenue from the Group's supply chain services business; and (ii) an increase in sales and distribution expenses during the reporting period.